% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Piccardo:909624,
      author       = {Piccardo, Arnoldo and Albert, Nathalie L. and Borgwardt,
                      Lise and Fahey, Frederic H. and Hargrave, Darren and
                      Galldiks, Norbert and Jehanno, Nina and Kurch, Lars and Law,
                      Ian and Lim, Ruth and Lopci, Egesta and Marner, Lisbeth and
                      Morana, Giovanni and Young Poussaint, Tina and Seghers,
                      Victor J. and Shulkin, Barry L. and Warren, Katherine E. and
                      Traub-Weidinger, Tatjana and Zucchetta, Pietro},
      title        = {{J}oint {EANM}/{SIOPE}/{RAPNO} practice guidelines/{SNMMI}
                      procedure standards for imaging of paediatric gliomas using
                      {PET} with radiolabelled amino acids and [18{F}]{FDG}:
                      version 1.0},
      journal      = {European journal of nuclear medicine and molecular imaging},
      volume       = {49},
      number       = {11},
      issn         = {0340-6997},
      address      = {Heidelberg [u.a.]},
      publisher    = {Springer-Verl.},
      reportid     = {FZJ-2022-03295},
      pages        = {3852 - 3869},
      year         = {2022},
      abstract     = {Positron emission tomography (PET) has been widely used in
                      paediatric oncology. 2-Deoxy-2-[18F]fluoro-D-glucose
                      ([18F]FDG) is the most commonly used radiopharmaceutical for
                      PET imaging. For oncological brain imaging, different amino
                      acid PET radiopharmaceuticals have been introduced in the
                      last years. The purpose of this document is to provide
                      imaging specialists and clinicians guidelines for
                      indication, acquisition, and interpretation of [18F]FDG and
                      radiolabelled amino acid PET in paediatric patients affected
                      by brain gliomas. There is no high level of evidence for all
                      recommendations suggested in this paper. These
                      recommendations represent instead the consensus opinion of
                      experienced leaders in the field. Further studies are needed
                      to reach evidence-based recommendations for the applications
                      of [18F]FDG and radiolabelled amino acid PET in paediatric
                      neuro-oncology. These recommendations are not intended to be
                      a substitute for national and international legal or
                      regulatory provisions and should be considered in the
                      context of good practice in nuclear medicine. The present
                      guidelines/standards were developed collaboratively by the
                      EANM and SNMMI with the European Society for Paediatric
                      Oncology (SIOPE) Brain Tumour Group and the Response
                      Assessment in Paediatric Neuro-Oncology (RAPNO) working
                      group. They summarize also the views of the Neuroimaging and
                      Oncology and Theranostics Committees of the EANM and reflect
                      recommendations for which the EANM and other societies
                      cannot be held responsible.Keywords: DOPA; FDG; FET;
                      Gliomas; MET; PET-CT; Paediatric PET; Paediatric brain
                      imaging; Paediatric oncology.},
      cin          = {INM-3},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-3-20090406},
      pnm          = {5252 - Brain Dysfunction and Plasticity (POF4-525)},
      pid          = {G:(DE-HGF)POF4-5252},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {35536420},
      UT           = {WOS:000793100100001},
      doi          = {10.1007/s00259-022-05817-6},
      url          = {https://juser.fz-juelich.de/record/909624},
}